Entity Details

Primary name QDPR
Entity type gene
Source Source Link

Details

PrimaryID5860
RefseqGeneNG_008763
SymbolQDPR
Namequinoid dihydropteridine reductase
Chromosome4
Location4p15.32
TaxID9606
Statuslive
SourceGenomegenomic
SourceOriginnatural
CreationDate1998-08-25
ModificationDate2021-06-11

Ontological Relatives

UniProt IDsDHPR_HUMAN

GO terms

Show/Hide Table
GOName
GO:0001889 liver development
GO:0004155 6,7-dihydropteridine reductase activity
GO:0005737 cytoplasm
GO:0005829 cytosol
GO:0006520 cellular amino acid metabolic process
GO:0006558 L-phenylalanine metabolic process
GO:0006559 L-phenylalanine catabolic process
GO:0006729 tetrahydrobiopterin biosynthetic process
GO:0009055 electron transfer activity
GO:0010044 response to aluminum ion
GO:0010288 response to lead ion
GO:0033762 response to glucagon
GO:0035690 cellular response to drug
GO:0042802 identical protein binding
GO:0043005 neuron projection
GO:0051066 dihydrobiopterin metabolic process
GO:0070062 extracellular exosome
GO:0070402 NADPH binding
GO:0070404 NADH binding

Diseases

Show/Hide Table
Disease IDSourceNameDescription
261630 OMIMHyperphenylalaninemia, BH4-deficient, C (HPABH4C)Rare autosomal recessive disorder characterized by hyperphenylalaninemia and severe neurologic symptoms (malignant hyperphenylalaninemia) including axial hypotonia and truncal hypertonia, abnormal thermogenesis, and microcephaly. These signs are attributable to depletion of the neurotransmitters dopamine and serotonin, whose syntheses are controlled by tryptophan and tyrosine hydroxylases that use BH-4 as cofactor. Patients do not respond to phenylalanine-restricted diet. HPABH4C is lethal if untreated. The disease is caused by variants affecting the gene represented in this entry.